NCT02086695
- Conditions
- Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +6 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
- St. Boniface General Hospital Winnipeg, Manitoba, Canada
Clinical trial condition
Explore clinical trials studying Cardiotoxicity. Study availability and eligibility vary by location and protocol.
NCT02086695
NCT00002900
NCT00377559
NCT00968682
NCT00459771
NCT00854568
NCT00003937
NCT00003070
NCT00005578
NCT01246778